For example, somatostatin (SST) has been linked to abnormal levels of neuropeptides, impaired function, and hyperactivity of SST-positive interneurons (SST-IN) co-localized with amyloid-β plaques in AD [49,50]. Here, SST is linked to Alzheimer disease.